Re: [MOL] Marty: [06337] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] Marty:



Dear Lillian,

On our trip to Pennsylvania in September we will be making a side trip
to Washington, D.C. I have an appointment with the two congresspeople of
our District as well as the Senator who was just able to pass a bill of
Ovarian screening. We all have had phone conversations over the past few
days and will be meeting there for meeting with the N.C.I. and the
Clearing House of Alternative Medicine as well. Our focus is to bring
the new drugs and a number of new promising drugs into the forefront for
possible screening of those diseases such as uterine, ovarian that are
not easily detectable. I believe that the new drugs may play an
important role in cancer detection for many or most diseases. Wish us
luck. I will keep all posted here as quickly as I receive news on these
drugs (endostatin/angiostatin) and any new drug that is promising and
there are a few, and many of which are not in the chemo family, but the
family of genetics, angeiogenesis.

God Bless
marty auslander


firefly wrote:
> 
> The news about the two drugs keeps getting better all the time.  I pray they
> will push the trials as fast as they can and then get the meds. to all those
> cancering.  Who know's this could be the vaccine even, ever thought of that?
> It's the best news there is besides our friends who have had good test
> results.  Pls, Pls, keep us up on this.
> Your friend Lillian
> 
>
------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------